Promoting access to COVID-19 convalescent plasma in low- and middle-income countries

Low- and middle-income countries (LMICs) remain neglected in the Coronavirus 19 (COVID-19) pandemic. COVID-19 convalescent plasma (CCP) (i.e. plasma collected from individuals after their recovery from COVID-19) has emerged as a leading medical treatment for COVID-19. Studies to date support the saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloch, Evan M., Goel, Ruchika, Montemayor, Celina, Cohn, Claudia, Tobian, Aaron A.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502258/
https://www.ncbi.nlm.nih.gov/pubmed/32972861
http://dx.doi.org/10.1016/j.transci.2020.102957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502258/
https://www.ncbi.nlm.nih.gov/pubmed/32972861
http://dx.doi.org/10.1016/j.transci.2020.102957

Ejemplares similares